Distortion Therapy

Price Rationale

Distortion Therapy is an early SuperRare XCOPY 1/1 minted and released on 2018-11-16, with two exact onchain sales in the supplied record: 0.45 ETH / $78.73 on 2018-11-16 and 3.5 ETH / $500.78 on 2019-12-14, the latter being both last and highest onchain sale. The final mark weights that exact-token 3.5 ETH sale most heavily, then adjusts moderately upward for early-2018 XCOPY 1/1 scarcity and the supplied nearest peer above, Your new favourite t-shirt arrived, at 5.2 ETH on 2020-08-31. Current ask ETH and current best bid ETH are null, no OTC sales are recorded, and the work is not grail-flagged, so the final value stays close to the market/liquidity/cycle appraiser consensus rather than adopting the higher cultural-canon center. Because ETH/USD snapshot is null, no current USD conversion is inferred.

What Caps The Price

A higher final value would require stronger live or executed evidence than the supplied packet provides: there is no current best bid, no current ask, no OTC sale, no recent exact-token sale, and no grail flag. The 5.2 ETH same-theme peer and the cultural reading support upside, but they do not justify pushing materially above the mid-5 ETH ask zone when the exact token last cleared at 3.5 ETH / $500.78 in 2019 and has no current demand quote.

What Supports The Price

A lower final value would underweight the token's clean early SuperRare XCOPY 1/1 status, its exact-token 3.5 ETH highest sale, and the supplied 5.2 ETH peer selected for adjacent consumer-harm / advertising-sickness satire. Thin liquidity and stale sales lower confidence and widen the bid/ask spread, but they do not erase the early-XCOPY provenance or justify treating the 2019 print as a hard ceiling.